Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intramuscular dexmedetomidine for delirium prevention in older non-ventilated ICU patients
ACTRN12625000103460Phase 2Not yet recruiting
- Sponsor
- Monash Health
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexmedetomidine in delirium, critical illness, sponsored by Monash Health. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
deliriumcritical illness
Beyond the preview
Go deeper on ACTRN12625000103460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625000103460.